Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to Outperform from Perform, citing a favorable valuation setup ahead of a ...

Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $-0.13. Operator: Good day, and thank you for standing by. Welcome to the Nektar Therapeutics ...

Nektar Therapeutics (NKTR) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to loss of $0.22 per share a year ago.

Good day, and thank you for standing by. Welcome to the Nektar Therapeutics Fourth Quarter 2024 financial results conference call. At this time, all participants are in a listen-only mode.

Tame the Web MIDI API. Send and receive MIDI messages with ease. Control instruments with user-friendly functions (playNote, sendPitchBend, etc.). React to MIDI input with simple event listeners ...

While Microsoft Loop and OneNote target different audiences, their fundamentals are the same: to enhance productivity. Whether you're capturing fleeting thoughts, collaborating on complex projects ...

Yes, it has shin-destroyingly long pins, but the new Race Face Turbine pedal uses more than spiky bits to keep your foot from coming off. Some people (guilty) think that a glued-on feeling only comes ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...